Publications

Journal Article
Research Support, U.S. Gov't, P.H.S.
Ppublish 103 citations
Electronic publication date
July 1, 1996

View on Pubmed.gov 8676446 | View on doi.org 10.1128/JVI.70....

Immune evasion properties of herpes simplex virus type 1 glycoprotein gC.

Search for publications in this journal J Virol - 70(7):4253-60

  • H M Friedman

    Search for this expert
    1
  • L Wang

    Search for this expert
  • N O Fishman

    Search for this expert
  • J D Lambris
  • R J Eisenberg

    Search for this expert
  • G H Cohen

    Search for this expert
  • J Lubinski

Abstract

Herpes simplex virus type I (HSV-1) glycoprotein gC binds complement component C3b, and purified gC inhibits complement activation. Two HSV strains carrying mutations in the gC gene which rendered them unable to bind C3b were compared with wild-type and marker-rescued viruses to evaluate the role of gC on the virion in protecting HSV-1 from complement-mediated neutralization. The gC mutant viruses were markedly susceptible to neutralization by nonimmune human serum, showing up to a 5,000-fold decline in titer after 1 h of incubation with serum. In contrast, wild-type or marker-rescued viruses showed a twofold reduction in titer. Studies with hypogammaglobulinemic and immunoglobulin G-depleted serum supported the observation that neutralization occurred in the absence of antibody. Neutralization of gC mutant strains by nonimmune serum was rapid; their half-life was 2 to 2.5 min, compared with 1 h for wild-type virus. Ethylene glycol-bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA)-treated human serum or C4-deficient guinea pig serum failed to neutralize gC mutant strains, indicating a role for components of the classical complement pathway. gC had little additional effect on neutralization by the combination of antibody plus complement compared with complement alone. The results indicate that the magnitude of the protection offered by gC-1 is larger than previously recognized; that in the absence of gC-1, complement neutralization is rapid and is mediated by components of the classical complement pathway; and that gC mainly protects against antibody-independent complement neutralization, suggesting a probable role for gC early in infection, before antibodies develop.

References

Nature. 1991 Dec 12;354(6353):453-9

Nature. 1996 Jan 4;379(6560):85-8

J Immunol. 1992 May 15;148(10):3210-5

J Virol. 1992 Jun;66(6):3937-40

Cited by 103 citations (total)

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Optimal replication of human cytomegalovirus correlates with endocytosis of glycoprotein gpUL132.

Electronic publication date August 12, 2010

Search for publications in this journal J Virol

Barbara Kropff [...] Michael Mach et al.

Envelopment of a herpesvirus particle is a complex process of which much is still to be learned. We previously identified...

Journal Article Review

Experimental investigation of herpes simplex virus latency.

Electronic publication date July 1, 1997

Search for publications in this journal Clin Microbiol Rev

E K Wagner [...] D C Bloom et al.

The clinical manifestations of herpes simplex virus infection generally involve a mild and localized primary infection followed by asymptomatic (latent)...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances